In isolated rat islets, GLP-1 acts as a growth factor in a dose-dependent manner to increase the incorporation of tritiated thymidine and promotes cell proliferation through the upregulation of PI3K-mediated pathways (Buteau et al., 1999)
Research suggests GLP-1 medications may reduce certain inflammatory pathways directly, while also lowering inflammation indirectly through weight loss, improved insulin resistance, and reduced visceral fat
Vitamin B12, also known as cobalamin, is a water-soluble vitamin that plays a vital role in various bodily functions
FAQs About GLP-1 and Weight Loss Some patients see changes within the first month, but significant results typically become visible between 23 months
PMID: 27752075
In this sustained inflammatory environment, VSMCs switch from a differentiated contractile phenotype to a synthetic phenotype, marked by enhanced proliferation, migration toward the vascular lumen, and production of ECM